Standout Papers

Tumour burden and efficacy of immune-checkpoint inhibitors 2021 2026 2022 2024190
  1. Tumour burden and efficacy of immune-checkpoint inhibitors (2021)
    Filippo Gustavo Dall’Olio, Aurélien Marabelle et al. Nature Reviews Clinical Oncology
  2. Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies (2021)
    Mihaela Aldea, Fabrice André et al. Cancer Discovery

Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

Traditional Chinese medicine in lung cancer treatment
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
1 intermediate paper

Works of Mihaela Aldea being referenced

Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
2021 Standout
Tumour burden and efficacy of immune-checkpoint inhibitors
2021 Standout

Author Peers

Author Last Decade Papers Cites
Mihaela Aldea 281 501 183 381 86 1.1k
Xianghua Wu 333 510 192 573 68 1.3k
Moo Jun Baek 190 475 237 508 74 1.2k
Elżbieta Nowara 169 520 218 350 65 1.0k
Heming Li 183 455 317 483 56 1.1k
Eunsung Jun 228 598 185 317 69 1.1k
Hongxue Meng 252 306 243 461 99 1.3k
Giacomo Miserocchi 330 486 169 271 61 985
Navid Sobhani 395 576 241 524 57 1.2k
Hani M. Babiker 360 649 268 348 147 1.4k
Yanqiu Zhao 405 442 187 367 99 970

All Works

Loading papers...

Rankless by CCL
2026